Eli Lilly and Company
INSULIN AND PRAMLINTIDE DELIVERY SYSTEMS, METHODS, AND DEVICES
Last updated:
Abstract:
The present disclosure relates to systems and methods for controlling physiological glucose concentrations in a patient.
Status:
Application
Type:
Utility
Filling date:
20 Jun 2019
Issue date:
5 Aug 2021